GRIN1 and psychiatric disorder: In addition, there have been many studies on the potential effects of blood circulating anti-NMDAR1 autoantibodies on psychiatric disorders (Castillo-Gomez et al., 2017; Hammer et al., 2014; Jezequel et al., 2017; Pan et al., 2019), cognitive functions (Yue et al., 2021), and neurodegenerative diseases (Hopfner et al., 2019).